Welcome : Guest

The Promising Advantages of Reduced Costs & Faster Time-to-Market Drive the Popularity of Medical Device Outsourcing Among OEMs

Published: November 2017


  • Code: MCP-6556
  • Pages: 301
  • Tables: 122
  • Companies: 59


The global market for Medical Device Outsourcing is projected to reach US$101.7 billion by 2024, driven by the rising pressure to reduce manufacturing costs and accelerate time-to-market new products in a scenario where product lifecycles are getting shorter, technologies are becoming increasingly sophisticated and the window of opportunity keeps continuously shrinking. Also supporting growth in the number of outsourcing contracts is the rising incidence of diseases specifically cardiac and neurological disorders and the ensuing higher demand for a wide variety of medical devices such as cardiac monitors, implanted cerebella stimulators, and replacement heart valves, among others. The United States represents the largest market worldwide. Asia-Pacific is forecast to record the fastest CAGR of 14.6% over the analysis period, led by the emergence of the region as the global hub for medical manufacturing due to low labor costs and higher focus on adherence to stringent international quality standards; and formulation of favorable policies and strategies to encourage growth of Asian economies as cost-effective destinations for medical device and instrumentation production. 

    Summary of Findings

  • Better Understanding of the Electrochemical Processes of the Brain and Development of Disease-Modifying Therapies to Drive Growth in the Antiepileptic Drugs Market
  • Ability to Offer Additive Benefits and Target Multiple Pathologic Processes Simultaneously Drive Demand for Combination CNS Therapies
  • Development of Neuro Protective Drugs & New Alzheimer’s Drugs Engineered to Target Toxic Amyloid Proteins in the Brain to Support Long-Term Growth in the Market
  • Increase in CNS Prescriptions for Pain Manifestations and Psychiatric Disorders to Benefit Demand
  • Growing Focus on Healthcare Cost Containment and Rationalization Spurs Sales of Generic CNS Medications

    Timeline for Analysis

  • Market Estimates and Forecasts for 2016-2024
  • Historic Review 2011-2015

    Geographic Markets Analyzed

  • US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific, and Rest of World

    Market Segmentation & Classification

  • Device Category :
    • Class I, Class II, and Class III
  • Application Area:
    • Radiology, Orthopedic, Neurology, Cardiology, and Others


  • Benchmark Electronics, Inc.
  • Cadence, Inc.
  • Creganna Medical
  • Celestica, Inc.
  • CoorsTek Medical LLC
  • Flextronics International


  • Review of Industry/Market Structure
  • Analysis of Trends & Drivers
  • Insights on Macro Market Scenarios
  • Market SWOT Analysis
  • Latent Demand Forecasts & Projections
  • Comprehensive Geographic Market Analysis
  • Presentation Ready Facts & Statistical Data Findings
  • Coverage of Major/Niche Players, Market Shares & Competition
  • Coverage of major Company/Technology/Product/Financial Stories
  • Extensive Product/Service/End-Use/Technology Coverage Where Applicable

Interested in our research, you can contact our 24/7 Research Support e-Desk at rsd@strategyr.com